These results suggest that USP13 overexpression not only accelerates ovarian tumor development but also promotes the metastatic ability of these ovarian tumors, while conditional inactivation of Pten and Trp53 in OSE is not sufficient for the development of metastatic ovarian cancer. This evidence concerns the gene USP13 and ovarian neoplasm.